FOI Request - Weight Loss Drugs

Request 101003842768

The number of enforcement actions, complaints and investigations related to the unlicensed sale or prescription of semaglutide, tirzepatide and liraglutide, between January 1, 2020 and the present day, broken down by calendar year and type of drug.

Response 16-09-2025

Not held. This is not a Trading Standards remit. Information that is not held falls under Section 17 of the Freedom of Information (Scotland) Act 2002 - Information not held.

In order to be helpful we suggest contacting the General Pharmaceutical Council or MHRA.